Topical Agents

Clinical Research Poster
Treatment of Burns with Concentrated Surfactant Technology
10/18/2018
BACKGROUND: Since the presence of necrosis increases the chances of infection and delays healing, most deeper burns are treated with excision, followed by, depending on the depth, autografting or use of a dressing. Debridement is painful and...
BACKGROUND: Since the presence of necrosis increases the chances of infection and delays healing, most deeper burns are treated with excision, followed by, depending on the depth, autografting or use of a dressing. Debridement is painful and...
BACKGROUND: Since the presence...
10/18/2018
Wounds
Educational Report
Topical Use of Concentrated Surfactant Technology for Removal of Nonviable Tissue and Wound Bed Preparation
10/12/2018
BACKGROUND: Wound bed preparation by removal of various barriers to wound healing, such as nonviable tissue and associated microbiome, is a fundamental principle of wound bed preparation. Timely removal of debris is essential for the...
BACKGROUND: Wound bed preparation by removal of various barriers to wound healing, such as nonviable tissue and associated microbiome, is a fundamental principle of wound bed preparation. Timely removal of debris is essential for the...
BACKGROUND: Wound bed...
10/12/2018
Wounds
Clinical Research Poster
Treatment of Pediatric Burns with Concentrated Surfactant Gel Technology (CST) with or Without an Antimicrobial Agent
10/11/2018
OBJECTIVE: A concentrated surfactant gel technology (CST) gel was designed to aid in maintaining moist wound healing and to soften debris, assisting in surfactant driven autolytic debridement. A clinical study was conducted to look at its...
OBJECTIVE: A concentrated surfactant gel technology (CST) gel was designed to aid in maintaining moist wound healing and to soften debris, assisting in surfactant driven autolytic debridement. A clinical study was conducted to look at its...
OBJECTIVE: A concentrated...
10/11/2018
Wounds
Educational Report
Economic Model for Cost Containment: Evaluating the Utilization of a Touch-Free Zinc Oxide in an Acute Care Hospital
10/11/2018
BACKGROUND: Incontinence-associated dermatitis (IAD) is a major concern with hospitalized patients and puts them at higher risk for skin breakdown and ulceration. Zinc oxide has been proven to prevent and treat IAD. Hospitals are constantly...
BACKGROUND: Incontinence-associated dermatitis (IAD) is a major concern with hospitalized patients and puts them at higher risk for skin breakdown and ulceration. Zinc oxide has been proven to prevent and treat IAD. Hospitals are constantly...
BACKGROUND:...
10/11/2018
Wounds
Clinical Research Poster
Comparing a High-concentration Topical Surfactant With and Without a Topical Antimicrobial in the Management of Burns
10/10/2018
OBJECTIVE: A surface-acting agent based on concentrated surfactant technology (CST), in certain patients in combination with a topical antimicrobial agent, was studied for both debriding properties and wound healing-related aspects in a trial...
OBJECTIVE: A surface-acting agent based on concentrated surfactant technology (CST), in certain patients in combination with a topical antimicrobial agent, was studied for both debriding properties and wound healing-related aspects in a trial...
OBJECTIVE: A surface-acting...
10/10/2018
Wounds
Case Series
Management of Aplasia Cutis Congenita in Neonates: The Role of Topical Leptospermum Honey
10/10/2018
BACKGROUND: Aplasia cutis congenita (ACC) is an uncommon, heterogeneous group of disorders characterized by focal or widespread absence of skin from certain parts of the body. Complications of ACC include infections, meningitis, bleeding,...
BACKGROUND: Aplasia cutis congenita (ACC) is an uncommon, heterogeneous group of disorders characterized by focal or widespread absence of skin from certain parts of the body. Complications of ACC include infections, meningitis, bleeding,...
BACKGROUND: Aplasia cutis...
10/10/2018
Wounds
Original Research
Durability of an Advanced Skin Protectant Compared With Other Commercially Available Products in Healthy Human Volunteers
09/01/2018
09/01/2018
Wounds
Case Series
Effect of a New Purified Collagen Matrix With Polyhexamethylene Biguanide on Recalcitrant Wounds of Various Etiologies: A Case Series
02/28/2018
In order to control biofilm formation, sequester proteolytic enzymes, and provide a biocompatible scaffold to support healing, the investigators utilize a purified collagen matrix containing polyhexamethylene biguanide (PCMP) in a case series...
In order to control biofilm formation, sequester proteolytic enzymes, and provide a biocompatible scaffold to support healing, the investigators utilize a purified collagen matrix containing polyhexamethylene biguanide (PCMP) in a case series...
In order to control biofilm...
02/28/2018
Wounds
Original Research
Comprehensive In Situ Killing of Six Common Wound Pathogens With Manuka Honey Dressings Using a Modified AATCC-TM100
06/29/2017
06/29/2017
Wounds
Case Series
Treatment of Recalcitrant Wounds of Diverse Etiology With a New Hydroactive Gel
09/15/2009
09/15/2009
Wounds

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use